Chapter/Section Purchase

Leave This Empty:

Global IVD Infectious Disease Market Insights and Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Infectious Disease Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biochemical Diagnosis
1.2.3 Immune Diagnosis
1.2.4 Molecular Diagnosis
1.2.5 Microbiological Diagnosis
1.2.6 Urine Diagnosis
1.2.7 Coagulation Diagnosis
1.2.8 Other
1.3 Market by Application
1.3.1 Global IVD Infectious Disease Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Personal
1.3.3 Commercial
1.3.4 Academic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global IVD Infectious Disease Market Perspective (2017-2028)
2.2 IVD Infectious Disease Growth Trends by Region
2.2.1 IVD Infectious Disease Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 IVD Infectious Disease Historic Market Size by Region (2017-2022)
2.2.3 IVD Infectious Disease Forecasted Market Size by Region (2023-2028)
2.3 IVD Infectious Disease Market Dynamics
2.3.1 IVD Infectious Disease Industry Trends
2.3.2 IVD Infectious Disease Market Drivers
2.3.3 IVD Infectious Disease Market Challenges
2.3.4 IVD Infectious Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVD Infectious Disease Players by Revenue
3.1.1 Global Top IVD Infectious Disease Players by Revenue (2017-2022)
3.1.2 Global IVD Infectious Disease Revenue Market Share by Players (2017-2022)
3.2 Global IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IVD Infectious Disease Revenue
3.4 Global IVD Infectious Disease Market Concentration Ratio
3.4.1 Global IVD Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Disease Revenue in 2021
3.5 IVD Infectious Disease Key Players Head office and Area Served
3.6 Key Players IVD Infectious Disease Product Solution and Service
3.7 Date of Enter into IVD Infectious Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Infectious Disease Breakdown Data by Type
4.1 Global IVD Infectious Disease Historic Market Size by Type (2017-2022)
4.2 Global IVD Infectious Disease Forecasted Market Size by Type (2023-2028)
5 IVD Infectious Disease Breakdown Data by Application
5.1 Global IVD Infectious Disease Historic Market Size by Application (2017-2022)
5.2 Global IVD Infectious Disease Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America IVD Infectious Disease Market Size (2017-2028)
6.2 North America IVD Infectious Disease Market Size by Type
6.2.1 North America IVD Infectious Disease Market Size by Type (2017-2022)
6.2.2 North America IVD Infectious Disease Market Size by Type (2023-2028)
6.2.3 North America IVD Infectious Disease Market Share by Type (2017-2028)
6.3 North America IVD Infectious Disease Market Size by Application
6.3.1 North America IVD Infectious Disease Market Size by Application (2017-2022)
6.3.2 North America IVD Infectious Disease Market Size by Application (2023-2028)
6.3.3 North America IVD Infectious Disease Market Share by Application (2017-2028)
6.4 North America IVD Infectious Disease Market Size by Country
6.4.1 North America IVD Infectious Disease Market Size by Country (2017-2022)
6.4.2 North America IVD Infectious Disease Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe IVD Infectious Disease Market Size (2017-2028)
7.2 Europe IVD Infectious Disease Market Size by Type
7.2.1 Europe IVD Infectious Disease Market Size by Type (2017-2022)
7.2.2 Europe IVD Infectious Disease Market Size by Type (2023-2028)
7.2.3 Europe IVD Infectious Disease Market Share by Type (2017-2028)
7.3 Europe IVD Infectious Disease Market Size by Application
7.3.1 Europe IVD Infectious Disease Market Size by Application (2017-2022)
7.3.2 Europe IVD Infectious Disease Market Size by Application (2023-2028)
7.3.3 Europe IVD Infectious Disease Market Share by Application (2017-2028)
7.4 Europe IVD Infectious Disease Market Size by Country
7.4.1 Europe IVD Infectious Disease Market Size by Country (2017-2022)
7.4.2 Europe IVD Infectious Disease Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IVD Infectious Disease Market Size (2017-2028)
8.2 Asia-Pacific IVD Infectious Disease Market Size by Type
8.2.1 Asia-Pacific IVD Infectious Disease Market Size by Type (2017-2022)
8.2.2 Asia-Pacific IVD Infectious Disease Market Size by Type (2023-2028)
8.2.3 Asia-Pacific IVD Infectious Disease Market Share by Type (2017-2028)
8.3 Asia-Pacific IVD Infectious Disease Market Size by Application
8.3.1 Asia-Pacific IVD Infectious Disease Market Size by Application (2017-2022)
8.3.2 Asia-Pacific IVD Infectious Disease Market Size by Application (2023-2028)
8.3.3 Asia-Pacific IVD Infectious Disease Market Share by Application (2017-2028)
8.4 Asia-Pacific IVD Infectious Disease Market Size by Region
8.4.1 Asia-Pacific IVD Infectious Disease Market Size by Region (2017-2022)
8.4.2 Asia-Pacific IVD Infectious Disease Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America IVD Infectious Disease Market Size (2017-2028)
9.2 Latin America IVD Infectious Disease Market Size by Type
9.2.1 Latin America IVD Infectious Disease Market Size by Type (2017-2022)
9.2.2 Latin America IVD Infectious Disease Market Size by Type (2023-2028)
9.2.3 Latin America IVD Infectious Disease Market Share by Type (2017-2028)
9.3 Latin America IVD Infectious Disease Market Size by Application
9.3.1 Latin America IVD Infectious Disease Market Size by Application (2017-2022)
9.3.2 Latin America IVD Infectious Disease Market Size by Application (2023-2028)
9.3.3 Latin America IVD Infectious Disease Market Share by Application (2017-2028)
9.4 Latin America IVD Infectious Disease Market Size by Country
9.4.1 Latin America IVD Infectious Disease Market Size by Country (2017-2022)
9.4.2 Latin America IVD Infectious Disease Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVD Infectious Disease Market Size (2017-2028)
10.2 Middle East & Africa IVD Infectious Disease Market Size by Type
10.2.1 Middle East & Africa IVD Infectious Disease Market Size by Type (2017-2022)
10.2.2 Middle East & Africa IVD Infectious Disease Market Size by Type (2023-2028)
10.2.3 Middle East & Africa IVD Infectious Disease Market Share by Type (2017-2028)
10.3 Middle East & Africa IVD Infectious Disease Market Size by Application
10.3.1 Middle East & Africa IVD Infectious Disease Market Size by Application (2017-2022)
10.3.2 Middle East & Africa IVD Infectious Disease Market Size by Application (2023-2028)
10.3.3 Middle East & Africa IVD Infectious Disease Market Share by Application (2017-2028)
10.4 Middle East & Africa IVD Infectious Disease Market Size by Country
10.4.1 Middle East & Africa IVD Infectious Disease Market Size by Country (2017-2022)
10.4.2 Middle East & Africa IVD Infectious Disease Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics IVD Infectious Disease Introduction
11.1.4 Roche Diagnostics Revenue in IVD Infectious Disease Business (2017-2022)
11.1.5 Roche Diagnostics Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories IVD Infectious Disease Introduction
11.2.4 Abbott Laboratories Revenue in IVD Infectious Disease Business (2017-2022)
11.2.5 Abbott Laboratories Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott IVD Infectious Disease Introduction
11.3.4 Abbott Revenue in IVD Infectious Disease Business (2017-2022)
11.3.5 Abbott Recent Developments
11.4 Gen-Probe
11.4.1 Gen-Probe Company Details
11.4.2 Gen-Probe Business Overview
11.4.3 Gen-Probe IVD Infectious Disease Introduction
11.4.4 Gen-Probe Revenue in IVD Infectious Disease Business (2017-2022)
11.4.5 Gen-Probe Recent Developments
11.5 Becton Dickinson (BD)
11.5.1 Becton Dickinson (BD) Company Details
11.5.2 Becton Dickinson (BD) Business Overview
11.5.3 Becton Dickinson (BD) IVD Infectious Disease Introduction
11.5.4 Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2017-2022)
11.5.5 Becton Dickinson (BD) Recent Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories IVD Infectious Disease Introduction
11.6.4 Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2017-2022)
11.6.5 Bio-Rad Laboratories Recent Developments
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare IVD Infectious Disease Introduction
11.7.4 Siemens Healthcare Revenue in IVD Infectious Disease Business (2017-2022)
11.7.5 Siemens Healthcare Recent Developments
11.8 Biom?rieux
11.8.1 Biom?rieux Company Details
11.8.2 Biom?rieux Business Overview
11.8.3 Biom?rieux IVD Infectious Disease Introduction
11.8.4 Biom?rieux Revenue in IVD Infectious Disease Business (2017-2022)
11.8.5 Biom?rieux Recent Developments
11.9 Danaher
11.9.1 Danaher Company Details
11.9.2 Danaher Business Overview
11.9.3 Danaher IVD Infectious Disease Introduction
11.9.4 Danaher Revenue in IVD Infectious Disease Business (2017-2022)
11.9.5 Danaher Recent Developments
11.10 Thermo Fisher
11.10.1 Thermo Fisher Company Details
11.10.2 Thermo Fisher Business Overview
11.10.3 Thermo Fisher IVD Infectious Disease Introduction
11.10.4 Thermo Fisher Revenue in IVD Infectious Disease Business (2017-2022)
11.10.5 Thermo Fisher Recent Developments
11.11 Sysmex
11.11.1 Sysmex Company Details
11.11.2 Sysmex Business Overview
11.11.3 Sysmex IVD Infectious Disease Introduction
11.11.4 Sysmex Revenue in IVD Infectious Disease Business (2017-2022)
11.11.5 Sysmex Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer